Copyright © 1988 by the European Society of Cardiology.
© 1988 The European Society of Cardiology
Breathlessness,lung function and the risk of heart attack
Department of Clinical Epidemiology and General Practice, Royal Free Hospital School of Medicine London NW3 2PF,U.K.
Received 29 February 1988; revised 20 May 1988; .
Abstract
Men with moderate of severe breathlessness had a greater than two-fold risk of suffering a major ischaemic heart disease (IHD)event compared to men with no evidence of breathlessness,based on 7.5-year follow-up in a prospective study of 7735 British men aged 4059 years. Even after adjustment for other risk factors, including cigarette smoking, the relative risk remained two-fold. Men in the lowest fifth of the forced expiratory volume is 1 s (FEV1)distribution also had a two-fold risk of IHD compared to men in the highest fifth after similar adjustment. In part, the role of breathlessness as a risk factor for major IHD events was explained by its strong association with pre-existing, but usually undiagnosed, IHD. However,breathlessness was associated with an increased risk of heart attack even in men without any evidence of pre-existing IHD at screening. FEV1 was related to risk of a major IHD event in men without evidence of pre-existing IHD at screening and in men withn previously undiagnosed IHD detected at screening. Measures of breathlessness and lung function could be more widely used in clinical situations and in screening as additional independent indicators of both unrecognized IHD and of risk for major IHD events.
Key Words: Breathlessness; lung function; heart attack
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Stavem, L. Sandvik, and J. Erikssen Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men? Chest, August 1, 2006; 130(2): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
H A Cowie, B G Miller, R G Rawbone, and C A Soutar Dust related risks of clinically relevant lung functional deficits. Occup. Environ. Med., May 1, 2006; 63(5): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abidov, A. Rozanski, R. Hachamovitch, S. W. Hayes, F. Aboul-Enein, I. Cohen, J. D. Friedman, G. Germano, and D. S. Berman Prognostic significance of dyspnea in patients referred for cardiac stress testing. N. Engl. J. Med., November 3, 2005; 353(18): 1889 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease Chest, November 1, 2005; 128(5): 3618 - 3624. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Schroeder, V. L. Welch, D. Couper, F. J. Nieto, D. Liao, W. D. Rosamond, and G. Heiss Lung Function and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., December 15, 2003; 158(12): 1171 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Dawkins, L J Dowson, P J Guest, and R A Stockley Predictors of mortality in {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1020 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force for the Diagnosis and Treatment of Chro, W. J. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure Eur. Heart J., September 1, 2001; 22(17): 1527 - 1560. [PDF] |
||||
![]() |
F. C. Lampe, P. H. Whincup, A. G. Shaper, S. G. Wannamethee, M. Walker, and S. Ebrahim Variability of Angina Symptoms and the Risk of Major Ischemic Heart Disease Events Am. J. Epidemiol., June 15, 2001; 153(12): 1173 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Truelsen, E. Prescott, P. Lange, P. Schnohr, and G. Boysen Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study Int. J. Epidemiol., February 1, 2001; 30(1): 145 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Hole, G C M Watt, G Davey-Smith, C L Hart, C R Gillis, and V M Hawthorne Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study BMJ, September 21, 1996; 313(7059): 711 - 715. [Abstract] [Full Text] |
||||
![]() |
S. G. Wannamethee, A. G. Shaper, and S. Ebrahim Respiratory Function and Risk of Stroke Stroke, November 1, 1995; 26(11): 2004 - 2010. [Abstract] [Full Text] |
||||
![]() |
G. Wannamethee, A. G. Shaper, P. W. Macfarlane, and M. Walker Risk Factors for Sudden Cardiac Death in Middle-Aged British Men Circulation, March 15, 1995; 91(6): 1749 - 1756. [Abstract] [Full Text] |
||||









